Welcome to the House Committee on Energy and Commerce

E&C is at the forefront of all issues and policies powering America’s economy, including our global competitive edge in energy, technology, and health care.

Established

December 14, 1795

30

Members

6

specialized subcommittees

The Latest

From the Committee

Jul 15, 2026

Press Release

Chairmen Guthrie and Hudson Announce Hearing on Protecting Communications Networks and Improving Connectivity

WASHINGTON, D.C. - Today, Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, and Congressman Richard Hudson (NC-09), Chairman of the Subcommittee on Communications and Technology, announced a hearing titled Legislative Hearing on Protecting Communications Networks and Improving Connectivit_y._

"Bad actors, whether adversarial nations or agents of chaos, often seek to exploit communications networks to carry out their objectives, so it is imperative that we in Congress do our part to secure our nation's communications networks and ensure that every American has access to the reliable connectivity that underpins the digital economy," said Chairmen Guthrie and Hudson. "This hearing will give Members the opportunity to examine legislation that aims to protect Americans from foreign threats, such as China, cut down on scammers and bad actors using illegal robocalls to target Americans, and expand access to the reliable broadband needed for the 21^st Century economy. We look forward to discussing and examining these bipartisan proposals as we work to keep families and businesses safe and connected."

Subcommittee on Communications and Technology hearing titled Legislative Hearing on Protecting Communications Networks and Improving Connectivity.

WHAT: Subcommittee on Communications and Technology hearing to consider legislation to protect communications networks and improve connectivity.

DATE: Wednesday, July 22, 2026

TIME: 2:00 PM ET

LOCATION: 2123 Rayburn House Office Building

The hearing will focus on the following bills:

H.R. 9129, GUARD Act (Reps. Moolenaar and McClellan)
H.R. 6152, Foreign Robocall Elimination Act (Reps. McDowell and Morrison)
H.R. 1027, QUIET Act (Reps. Sorensen and Ciscomani)
H.R. 7294, AI for Secure Networks Act (Reps. Menendez and Pfluger)
H.R. 2805, PLAN for Broadband Act (Reps. Walberg and Peters)
H.R. 4950, Data BRIDGE Act (Reps. Houchin and Kelly (IL)

This notice is at the direction of the Chairman. The hearing will be open to the public and press and will be live streamed online at energycommerce.house.gov. If you have any questions concerning the hearing, please contact Noah Jackson with the Committee staff at Noah.Jackson@mail.house.gov. If you have any press-related questions, please contact Daniel Kelly at Daniel.Kelly@mail.house.gov.

More News & Announcements

Jul 15, 2026

Environment

Environment Subcommittee Advances Seven Pieces of Legislation to Support Addressing Harmful Regulations and to Support Recycling

WASHINGTON, D.C. - Yesterday, Congressman Gary Palmer (AL-06), Chairman of the Subcommittee on Environment, led a markup of legislation to address harmful regulations on companies and to support their recycling efforts.

“The bills our Environment Subcommittee marked up yesterday support the recovery of critical minerals and materials from domestic sources,” said Chairman Palmer. “Rather than continuing to rely on adversaries such as China that dominate the critical minerals supply chain, we are taking the commonsense steps needed to safeguard our national security.”
Legislative Vote Summary:

H.R. 2140, the Diesel Emissions Reduction Act of 2025, was forwarded to the Full Committee, by voice vote.
H.R. 3194, the Lifting Overburdensome Commerce Obstructions and Motives (LOCOMOTIVES) Act, was forwarded to the Full Committee, by voice vote.
H.R. 9317, the B_uses Utilizing Safety and Environmental Standards (BUSES) Act_, was forwarded to the Full Committee, by voice vote.
H.R. 9615, the Battery Recycling for America's Competitive Economy (BRACE) Act, was forwarded to the Full Committee, as amended, by voice vote.
H.R. 9616, the Environmental Monitoring and Remediation Technology Assessment Initiative (EMRTAI) Act of 2026, was forwarded to the Full Committee, by voice vote.
H.R. 9617, the Coordinating and Harnessing America's Recovery of Minerals (CHARM) Act, was forwarded to the Full Committee, by voice vote.
H.R. 9618, the Diesel Engine Flexibility (DEF) Act, was forwarded to the Full Committee, as amended, by voice vote.

Watch the full markup here.

Below are key excerpts from today's markup:

Congressman Nick Langworthy (NY-23) on H.R. 9317, the Buses Utilizing Safety and Environmental Standards Act: "Buses are one of the safest and most efficient ways to move large numbers of people. They transport children to school, connect rural communities, and support our tourism industry. They move military personnel, and they provide critical transportation for millions of Americans every single year. The rules governing these operators should reflect what actually takes place to operate a bus safely, not create unnecessary obstacles. Here's the problem: buses don't idle because drivers want to. They idle because the job requires it. Before a bus can even begin its route, federal law requires drivers to complete safety inspections. They need to maintain brake pressure, operate wheelchair lifts and other accessibility equipment, and safely board passengers with disabilities. And where I come from in western New York, keeping passengers warm during the winter is often a matter of safety, not convenience."

Congressman Buddy Carter (GA-01) on H.R. 3194, the Lifting Overburdensome Commerce Obstructions and Motives Act: "H.R. 3194 is a commonsense bill created in response to California's attempt to impose zero-emission locomotive mandates that would dramatically increase the prices of goods and have serious consequences for freight rail. This bill will close the loophole which allows the California Air Resources Board to request waivers from EPA that allow the state to issue overreaching mandates. These mandates would empower California to impose its policies on the national rail system and govern interstate commerce. The CARB proposal would effectively ban a large portion of the national locomotive fleet from operating in California. This would mean higher prices for consumers, and it would not lead to cleaner air quality. The fact is that California is simply rushing to green without looking at the real-world consequences of their actions."

Congresswoman Mariannette Miller-Meeks, M.D. (IA-02) on H.R. 9615, the Battery Recycling for America's Competitive Economy Act: "Demand for lithium-ion batteries in the United States has grown exponentially in recent years, in large part due to demand for rechargeable batteries for energy storage systems, electric vehicles, communication devices, and other consumer goods. As more lithium-ion batteries reach the end of their life, the recycling and recovery of critical minerals from these batteries provides a tremendous opportunity for the United States to boost its supply chains for certain critical minerals. Critical minerals such as nickel, cobalt, lithium, and copper can be recovered from lithium-ion batteries. However, end-of-life batteries and scrap materials are largely sent overseas, often to China, for processing. Our subcommittee has heard testimony at two hearings that our own regulatory scheme under the Resource Conservation and Recovery Act, or RCRA, is contributing to these valuable minerals being sent overseas - and to this missed opportunity to recover critical minerals already present in our country."

Jul 15, 2026

Health

Chairman Griffith Delivers Opening Statement at Subcommittee on Health Hearing on Maintaining U.S. Leadership in Biomedical Innovation

WASHINGTON, D.C. - Congressman Morgan Griffith (VA-09), Chairman of the Subcommittee on Health, delivered the following opening statement at today's hearing titled Maintaining America's Leadership in Biomedical Innovation: FDA's Role in Advancing U.S. Drug Development.

Subcommittee Chairman Griffith's opening statement as prepared for delivery:

"Today's hearing will examine ways to maintain American leadership in biomedical innovation.

"This hearing is a great opportunity to learn more about what is working, where improvements can be made, and how Congress can ensure FDA continues to serve patients, promote innovation, and maintain our nation's leadership in biomedicine.

"The United States has always been the global leader in biopharmaceutical research and development, and it is important that we remain leaders in this space.

"However, other countries are catching up to the United States.

"It is important for Congress to reexamine our current landscape to ensure we are staying up to date with the latest biopharmaceutical advancements and examine what role Congress could play in making these processes more efficient.

"This Administration has proposed efforts to do so, such as the recent launch of FDA's Operation Trialblazer, announced in June.

"This is an HHS-wide effort that comes in response to the growing competitiveness of the global pharmaceutical landscape which promotes cross-agency collaboration to support research from the earliest stages of innovation.

"Operation Trialblazer provides a set of initiatives and reforms to modernize and accelerate medical product development, aiming to remove the unnecessary hurdles and ambiguity that sometimes hinder patient access to innovative treatments.

"Streamlining clinical trial requirements, encouraging use of modern trial designs and real-world evidence where appropriate, and reducing administrative burden can shorten development timelines and lower costs without compromising science or safety.

"These improvements have the potential to bring new treatments to patients faster, increase participation in clinical research, and make the United States even more attractive for investment in medical breakthroughs.

"It is important that we begin to have these conversations as this Subcommittee looks ahead to FDA's user fee reauthorization next year-especially as initiatives like Operation Trialblazer demonstrate that an approach to maintaining America's competitive edge involves improving the efficiency of drug development.

"For more than three decades, user fee programs have helped provide FDA with the resources to review innovative drugs and medical devices while maintaining the agency's rigorous standards for safety and effectiveness.

"Rather than relying solely on taxpayer dollars, user fees are paid by manufacturers that submit products for review, helping ensure the FDA has the scientific expertise and capacities necessary to keep pace with rapidly advancing medical innovation.

"Ultimately, user fees serve to improve health outcomes for patients.

"Every day that a safe and effective therapy reaches the market is another day that patients living with cancer, rare diseases, or other serious conditions may have access to life-changing or even life-saving treatments.

"The predictability and performance goals established through the user fee agreements have helped reduce review times, improve communication between FDA and product developers, and provide greater standardization throughout the review process.

"However, there is still more work that can be done, and reauthorization is not limited to just extending the status quo.

"Reauthorization gives Congress the opportunity to explore and write legislation so we can continue to work to streamline regulatory processes, reduce unnecessary administrative burden, strengthen communication with product developers, and ensure the agency has the tools it needs to make the best possible use of its resources.

"We can also continue to look for opportunities to modernize clinical trial networks, embedding them into routine care and expanding access to innovative treatments in rural communities.

"Maintaining America's position as the global leader in biomedical innovation requires a regulatory system that is both thorough and efficient.

"I am eager to look for ways that we can help ensure FDA can review drugs in a timely and predictable manner. Not only to expand patient access to innovative treatments, but to also encourage companies to invest, develop, and manufacture domestically.

"Thank you to the witnesses for being here this morning. I look forward to the discussion."

Jul 15, 2026

Health

Chairman Griffith Delivers Opening Statement at Subcommittee on Health Markup of Three Bills Combatting Illicit Drug Threats

WASHINGTON, D.C. - Congressman Morgan Griffith (VA-09), Chairman of the Subcommittee on Health, delivered the following opening statement at today's markup of three bills.

Subcommittee Chairman Griffith's opening statement as prepared for delivery:

"Today's markup will focus on a few bills that work to combat the illicit drug crisis facing our communities, specifically targeting the growing threat posed by pill presses.

"These bills work together to create regulatory framework that allows DEA to conduct oversight of a closed system of distribution for pill presses and their critical parts-just like we have for controlled substances.

"This system ensures good actors are able to utilize pill presses for legitimate intended uses, while giving DEA the tools to monitor suspicious orders and prevent bad actors from diverting pill presses for the illicit production of counterfeit pills.

"H.R. 5880, the Fight Illicit Pill Presses Act, is led by Representative Hageman from Wyoming, and would establish requirements for serial numbers, record keeping, and transaction reporting for pill presses and their critical parts.

"The Preventing Rogue Equipment for Synthetic Substances (PRESS) Act, H.R. 7184, is led by Representative McDowell from North Carolina.

"It would criminalize the importation of pill press equipment with the intent to illicitly produce a controlled substance.

"H.R. 8005, the Stop Pills that Kill Act, is led by Representative Evans from Colorado.

"This legislation would apply enhanced criminal penalties to those who engage in the illicit manufacture of fentanyl, fentanyl analogs, or fentanyl related substances.

"It would also direct the DEA to establish and implement a comprehensive plan to address the threat of counterfeit pills that contain fentanyl, methamphetamine, or any other illicit synthetic substance.

"I look forward to continuing to work on these policies and bringing them to the full Committee."

Trending Subcommittees

Full Committee

4 Updates

Energy

9 Updates

National Energy Policy, energy infrastructure and security, energy related Agencies and Commissions, all laws, programs, and government activities affecting energy matters. National Energy Policy focuses on fossil energy; renewable energy; nuclear energy; energy conservation, utility issues, including but not limited to interstate energy compacts; energy generation, marketing, reliability, transmission, siting, exploration, production, efficiency, cybersecurity, and ratemaking for all generated power. Energy infrastructure and security focuses on pipelines, the strategic petroleum reserve, nuclear facilities, and cybersecurity for our nation’s grid. Our jurisdiction also includes all aspects of the above-referenced jurisdiction related to the Department of Homeland Security. Agencies and Commissions in our jurisdiction include: The US Department of Energy, the Nuclear Regulatory Commission; and the Federal Energy Regulatory Commission.

Commerce, Manufacturing, and Trade

3 Updates

Interstate and foreign commerce, including all trade matters within the jurisdiction of the full committee; consumer protection, including privacy matters generally; data security; motor vehicle safety; regulation of commercial practices (the Federal Trade Commission), including sports-related matters; consumer product safety (the Consumer Product Safety Commission); product liability; and regulation of travel, tourism, and time. The Subcommittee’s jurisdiction can be directly traced to Congress’ constitutional authority “to regulate Commerce with foreign nations, and among the several States, and with the Indian Tribes.”

Communications & Technology

4 Updates

Electronic communications, both Interstate and foreign, including voice, video, audio and data, whether transmitted by wire or wirelessly, and whether transmitted by telecommunications, commercial or private mobile service, broadcast, cable, satellite, microwave, or other mode; technology generally; emergency and public safety communications; cybersecurity, privacy, and data security; the Federal Communications Commission, the National Telecommunications and Information Administration, the Office of Emergency Communications in the Department of Homeland Security; and all aspects of the above-referenced jurisdiction related to the Department of Homeland Security.

Environment

8 Updates

All matters related to soil, air, noise and water contamination; emergency environmental response, both physical and cybersecurity. In particular, the subcommittee has jurisdiction over The Nuclear Waste Policy Act, The Clean Air Act, The Safe Drinking Water Act, Comprehensive Environmental Response Compensation and Liability Act – including Superfund and the Emergency Planning and Community Right to Know Act, The Solid Waste Disposal Act, The Toxic Substance Control Act and The Chemical Facility Anti-Terrorism Standards Program. Under the Clean Air Act, this subcommittee deals with National Ambient Air Quality Standards (NAAQS) for criteria pollutants; National Emissions Standards for Hazardous Air Pollutants (NESHAP) Standards; New Source Performance Standards (NSPS); Mobile Source Standards for vehicles, aircraft, fuels and fuel additives, including the Renewable Fuel Standard (RFS) and greenhouse gas emissions from motor vehicles. The subcommittee focuses on the regulation of solid, hazardous, and nuclear wastes, including mining, nuclear, oil, gas, and coal combustion waste.

Health

14 Updates

The health sector broadly, including private and public health insurance (Patient Protection and Affordable Care Act, Medicare, Medicaid, CHIP); biomedical research and development; hospital construction; mental health; health information technology, privacy, and cybersecurity; medical malpractice and medical malpractice insurance; the 340B drug discount program; the regulation of food, drugs, and cosmetics; drug abuse; the Department of Health and Human Services; the National Institutes of Health; the Centers for Disease Control; Indian Health Service; and all aspects of the above-referenced jurisdiction related to the Department of Homeland Security.

Oversight & Investigations

5 Updates

Responsible for conducting oversight and investigations of any matter related to the jurisdiction of the full committee.

Recent Letters

Jul 15, 2026

Environment

Environment Subcommittee Advances Seven Pieces of Legislation to Support Addressing Harmful Regulations and to Support Recycling

H.R. 2140, the Diesel Emissions Reduction Act of 2025, was forwarded to the Full Committee, by voice vote.
H.R. 3194, the Lifting Overburdensome Commerce Obstructions and Motives (LOCOMOTIVES) Act, was forwarded to the Full Committee, by voice vote.
H.R. 9317, the B_uses Utilizing Safety and Environmental Standards (BUSES) Act_, was forwarded to the Full Committee, by voice vote.
H.R. 9615, the Battery Recycling for America's Competitive Economy (BRACE) Act, was forwarded to the Full Committee, as amended, by voice vote.
H.R. 9616, the Environmental Monitoring and Remediation Technology Assessment Initiative (EMRTAI) Act of 2026, was forwarded to the Full Committee, by voice vote.
H.R. 9617, the Coordinating and Harnessing America's Recovery of Minerals (CHARM) Act, was forwarded to the Full Committee, by voice vote.
H.R. 9618, the Diesel Engine Flexibility (DEF) Act, was forwarded to the Full Committee, as amended, by voice vote.